Specialty drugs: a distinctly American phenomenon

Naci, Huseyin

; and Kesselheim, Aaron S. (2020) Specialty drugs: a distinctly American phenomenon New England Journal of Medicine, 382 (23). 2179 - 2181. ISSN 0028-4793

Copy

Various stakeholders in the pharmaceutical supply chain assign the specialty label to drugs on the basis of a combination of several unrelated factors, including whether a drug treats a rare condition. But the single most common feature of specialty drugs is high cost.

Item Type	Article
Copyright holders	© 2020 Massachusetts Medical Society
Keywords	Cost Sharing/economics, Cost-Benefit Analysis, Drug Costs/legislation & jurisprudence, Drug Industry/legislation & jurisprudence, Government Regulation, Humans, Insurance Coverage/economics, Insurance, Pharmaceutical Services/economics, Medicaid/economics, Medicare Part D/economics, Patient Protection and Affordable Care Act, Pharmaceutical Preparations/economics, Rare Diseases/drug therapy, United States
Departments	Health Policy
DOI	10.1056/NEJMp1909513
Date Deposited	17 Jun 2020 15:21
Acceptance Date	2020-02-21
URI	https://researchonline.lse.ac.uk/id/eprint/105102

Explore Further

http://www.scopus.com/inward/record.url?scp=85085987506&partnerID=8YFLogxK (Scopus publication)
http://www.lse.ac.uk/health-policy/people/huseyin-naci-phd-mhs (Author)
https://www.nejm.org/ (Official URL)

picture_as_pdf

picture_as_pdf
subject: Published Version

Download

Atom

BibTeX

OpenURL ContextObject in Span

OpenURL ContextObject

Dublin Core

MPEG-21 DIDL

Data Cite XML

EndNote

HTML Citation

METS

MODS

RIOXX2 XML

Reference Manager

Refer

ASCII Citation

Export

Downloads